Login
Register
Submit a Paper
Propose a Special lssue
Open Access
RETRACTION
Retraction: Truncated Bid Overexpression Induced by Recombinant Adenovirus Cre/LoxP System Suppresses the Tumorigenic Potential of CD133+ Ovarian Cancer Stem Cells
Oncology Research 2026, 34(1), . https://doi.org/10.32604/or.2025.077268
Issue published 30 December 2025
This article is a retraction of:
Truncated Bid Overexpression Induced by Recombinant Adenovirus Cre/LoxP System Suppresses the Tumorigenic Potential of CD133+ Ovarian Cancer Stem Cells
Read original article
View Full Text
Download PDFAbstract
This article has no abstract.Cite This Article
APA Style
Oncology Research Editorial Office (2026). Retraction: Truncated Bid Overexpression Induced by Recombinant Adenovirus Cre/LoxP System Suppresses the Tumorigenic Potential of CD133<b>+</b> Ovarian Cancer Stem Cells. Oncology Research, 34(1). https://doi.org/10.32604/or.2025.077268
Vancouver Style
Oncology Research Editorial Office. Retraction: Truncated Bid Overexpression Induced by Recombinant Adenovirus Cre/LoxP System Suppresses the Tumorigenic Potential of CD133<b>+</b> Ovarian Cancer Stem Cells. Oncol Res. 2026;34(1). https://doi.org/10.32604/or.2025.077268
IEEE Style
Oncology Research Editorial Office, “Retraction: Truncated Bid Overexpression Induced by Recombinant Adenovirus Cre/LoxP System Suppresses the Tumorigenic Potential of CD133<b>+</b> Ovarian Cancer Stem Cells,” Oncol. Res., vol. 34, no. 1, 2026. https://doi.org/10.32604/or.2025.077268
Copyright © 2026 The Author(s). Published by Tech Science Press.This work is licensed under a Creative Commons Attribution 4.0 International License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Downloads
Citation Tools
